These are our products available in the United Kingdom please click on the name for the SPC and PIL information:

• Alprolix® 
• Ammonaps®
• Deflux®
• Elocta®
• Kepivance®
• Kineret®
• Megace tablets®
• Orfadin®
• Ravicti®
• Relistor®
• Solesta®
• Xiapex®

Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcardwww.mhra.gov.uk/yellowcard

Adverse events should also be reported to Swedish Orphan Biovitrum Limited by email: drugsafety@sobi.com, and for product complaints complaints@sobi.com. Alternatively, they can be reported to Sobi UK Ltd, telephone number +44 1223 891895.